Lehrstuhl für Haut- und Geschlechtskrankheiten

S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 update (2020) Schmidt E, Sticherling M, Sárdy M, Eming R, Goebeler M, Hertl M, Hofmann SC, et al. Journal article S2k-Leitlinie zur Therapie des Pemphigus vulgaris/foliaceus und des bullösen Pemphigoids: 2019 Update (2020) Schmidt E, Sticherling M, Sárdy M, Eming R, Goebeler M, Hertl M, Hofmann SC, et al. Journal article Cu, Zn doped borate bioactive glasses: antibacterial efficacy and dose-dependent in vitro modulation of murine dendritic cells (2020) Schuhladen K, Stich L, Schmidt J, Steinkasserer A, Boccaccini AR, Zinser E Journal article The CD83 Molecule – An Important Immune Checkpoint (2020) Grosche L, Knippertz I, König C, Royzman D, Wild A, Zinser E, Sticht H, et al. Journal article, Review article S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) - short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow-up, prevention and occupational disease (2020) Leiter U, Heppt M, Steeb T, Amaral T, Bauer A, Becker JC, Breitbart E, et al. Journal article S3-Leitlinie "Aktinische Keratose und Plattenepithelkarzinom der Haut" - Kurzfassung, Teil 2: Epidemiologie, chirurgische und systemische Therapie des Plattenepithelkarzinoms, Nachsorge, Pravention und Berufskrankheit (2020) Leiter U, Heppt MV, Steeb T, Amaral T, Bauer A, Becker JC, Breitbart E, et al. Journal article The ontogenetic path of human dendritic cells (2020) Amon L, Lehmann C, Heger L, Heidkamp GF, Dudziak D Journal article, Review article Transcriptional Analysis identifies long non-coding RNAs as potential biomarkers in pneumonia and COPD exacerbation (2020) Bertrams W, Griss K, Han M, Seidel K, Klemmer A, Sittka-Stark A, Hippenstiel S, et al. Conference contribution Transcriptional analysis identifies potential biomarkers and molecular regulators in pneumonia and COPD exacerbation (2020) Bertrams W, Griss K, Han M, Eberhardt M, Seidel K, Klemmer A, Sittka-Stark A, et al. Conference contribution Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients (2020) Amaral T, Kiecker F, Schaefer S, Stege H, Kaehler K, Terheyden P, Gesierich A, et al. Journal article